These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11483340)
1. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Ricardi U; Corrias A; Einaudi S; Genitori L; Sandri A; di Montezemolo LC; Besenzon L; Madon E; Urgesi A Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1287-94. PubMed ID: 11483340 [TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Chin D; Sklar C; Donahue B; Uli N; Geneiser N; Allen J; Nirenberg A; David R; Kohn B; Oberfield SE Cancer; 1997 Aug; 80(4):798-804. PubMed ID: 9264364 [TBL] [Abstract][Full Text] [Related]
4. Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols. Corrias A; Einaudi S; Ricardi U; Sandri A; Besenzon L; Altare F; Artesani L; Genitori L; Andreo M; De Sanctis C J Endocrinol Invest; 2001 Jun; 24(6):387-92. PubMed ID: 11434661 [TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Paulino AC Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595 [TBL] [Abstract][Full Text] [Related]
6. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918 [TBL] [Abstract][Full Text] [Related]
7. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615 [TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Allen JC; Donahue B; DaRosso R; Nirenberg A Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038 [TBL] [Abstract][Full Text] [Related]
9. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268 [TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250 [TBL] [Abstract][Full Text] [Related]
11. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368 [TBL] [Abstract][Full Text] [Related]
12. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Douglas JG; Barker JL; Ellenbogen RG; Geyer JR Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259 [TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. Lannering B; Rutkowski S; Doz F; Pizer B; Gustafsson G; Navajas A; Massimino M; Reddingius R; Benesch M; Carrie C; Taylor R; Gandola L; Björk-Eriksson T; Giralt J; Oldenburger F; Pietsch T; Figarella-Branger D; Robson K; Forni M; Clifford SC; Warmuth-Metz M; von Hoff K; Faldum A; Mosseri V; Kortmann R J Clin Oncol; 2012 Sep; 30(26):3187-93. PubMed ID: 22851561 [TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor. Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681 [TBL] [Abstract][Full Text] [Related]
17. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. Bonato C; Severino RF; Elnecave RH J Pediatr Endocrinol Metab; 2008 Oct; 21(10):943-9. PubMed ID: 19209616 [TBL] [Abstract][Full Text] [Related]
18. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544 [TBL] [Abstract][Full Text] [Related]
19. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study. Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079 [TBL] [Abstract][Full Text] [Related]
20. Modern treatment strategies in medulloblastoma. Kühl J Childs Nerv Syst; 1998; 14(1-2):2-5. PubMed ID: 9548331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]